Combined PECS II and Transversus Plane Blocks Versus Erector Spinae Block in Modified Radical Mastectomy
Breast Cancer, Acute Postoperative Pain

About this trial
This is an interventional prevention trial for Breast Cancer focused on measuring Breast Cancer, Regional Anaesthesia, Morphine Consumption
Eligibility Criteria
Inclusion Criteria:
- Age 18: 60 years old
- ASA (American Society of Anesthesiologists) physical status I II
- Female patients scheduled for modified radical mastectomy
Exclusion Criteria:
- Patient refusal or inability to give informed consent
- Subjects with a medical contraindication to regional anesthesia , such as coagulopathy, local infection or an allergy to local anesthetic
- Body mass index (BMI) >35
- Presence of psychiatric diseases
- History of chronic chest wall pain or neuropathic disorders
- Alcohol or drug abuse
- Severe chest wall deformities
Sites / Locations
- Assiut University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Combined PECS II and TTP blocks (PT)
Erector Spinae Block (E)
Modified Pectoralis block (PECS II) : Using ultrasound we proceed to inject 10 ml of bupivacaine 0.25% between the pectoral muscles and 10 ml under Pmm above the serratus muscle. Transversus Thoracic Plane block : 10 mL bupivacaine (0.25%) is injected between the transversus thoracic muscle and the internal intercostal muscle between the third and fourth left ribs connecting at the sternum.
Using ultrasound an echogenic 22-G block needle is inserted in-plane in a cranial-to-caudal direction until contact is made with the T5 transverse process. A total of 30 bupivacaine 0.25% is then injected while seeing the fluid lifting the erector spinae muscle off.